Late-breaking data from the STRIDE and SOUL studies show semaglutide improved symptoms, walking distance, and quality of life for patients with PAD, with SOUL also showing a reduction in adverse limb events. The lead authors of both studies joined a panel of multidisciplinary endovascular experts to unpack the implications of these findings, discuss the evolving landscape of medical therapies for PAD, and shared top-line takeaways for clinicians.
Moderator: Joshua Beckman, MD
Panelists: Marc P. Bonaca, MD, MPH
Brian DeRubertis, MD
Daniella Kadian-Dodov, MD
Darren McGuire, MD
Sahil Parikh, MD
Constantino Peña, MD
Originally recorded May 21, 2025.
Late-Breaking Clinical Trial presented by Dr. Manj Gohel at The VEINS 2024
Moderator: Raghu Kolluri, MD, MS
Panel: Venita Chandra, MD
Read More ...Late-Breaking Clinical Trial presented by Dr. Julie Bulman at The VEINS 2024
Moderator: Raghu Kolluri, MD, MS
Panel: Venita Chandra
Read More ...Late-Breaking Clinical Trial presented by Dr. Venita Chandra at VIVA24
Moderator: Eric A. Secemsky, MD, MSc
Panel: J. Fritz Angle
Read More ...Late-Breaking Clinical Trial presented by Dr. Brian DeRubertis at VIVA24
Moderator: Eric A. Secemsky, MD, MSc
Panel: J. Fritz Angle
Read More ...Late-Breaking Clinical Trial presented by Dr. Jay Giri at VIVA24
Moderator: Joshua Beckman, MD
Panel: Misty Humphries, MD; Zola N’Dandu
Read More ...Late-Breaking Clinical Trial presented by Dr. Parag Patel at VIVA24
Moderator: Ehrin Armstrong, MD
Panel: Bryan Fisher, MD; Raghu Kolluri, MD
Read More ...In this important VIVA24 session, experts examined variations in care across patient populations, combatting biases, and how we can move
Read More ...Award presenter: Niten Singh, MDATLAS award recipient: Peter A. Schneider, MD
After accepting the award, Dr. Schneider presents his ATLAS
Read More ...Late-Breaking Clinical Trial presented by Dr. Raghu Kolluri at VIVA23
Moderator: Parag J. Patel, MD, MS
Panel: Subhash Banerjee, MD; Jeff
Read More ...Late-Breaking Clinical Trial presented by Dr. Osamu Iida at VIVA23
Moderator: Sean Lyden, MD
Panel: Marc Bonaca, MD, MPH
Read More ...Dr. Yogen Kanthi presents "Pharmacotherapy in Preventing and Treating Thromboembolic Disease in Active Malignancy" at The VEINS 2023 as part
Read More ...Dr. Michael Dake presents the first annual ATLAS Lecture titled "Preparing for the Future: Building a Learning Environment While Addressing
Read More ...Late-breaking data from the STRIDE and SOUL studies show semaglutide improved symptoms, walking distance, and quality of life for patients
Read More ...In this clip from VIVA’s recent Data Deep Dive, Dr. Marc Bonaca presents new findings from the STRIDE-PAD study, leading
Read More ...Over the last two years, The VIVA Foundation, the American Venous Forum (AVF), and the American Vein and Lymphatic Society
Read More ...Bioresorbable scaffolds represent a novel option for treatment of below-the-knee lesions that offer advantages over permanent devices. New data show
Read More ...VIVA board members, field experts, and an FDA representative examined the evolution of the paclitaxel controversy and key takeaways for the future.
Originally broadcast July 17, 2023.
Moderators: Eric A. Secemsky, MD, MSc; Saher Sabri, MD; Peter A. Schneider, MD
Panelists: Joshua A. Beckman, MD; Venita Chandra
Read More ...The much-anticipated results from the BEST-CLI trial have provided side-by-side comparison of surgical and endovascular care of patients with critical limb-threatening ischemia (CLTI).
Originally broadcast December 8, 2022